Who owns BIOMARIN PHARMACEUTICAL?
- CUSIP Number: 09061gak7
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold BIOMARIN PHARMACEUTICAL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 102M | $98M | 32% | Sep 2025 |
|
| Lazard Asset Management | 55M | $532k | 131% | Dec 2025 |
|
| BlackRock | 42M | $40M | 11% | Dec 2025 |
|
| Man Group | 36M | $34M | 100% | Dec 2025 |
|
| Capstone Investment Advisors | 35M | $34M | 17% | Dec 2025 |
|
| MacKay Shields | 35M | $33M | -2% | Dec 2025 |
|
| Opti Capital Management | 32M | $31B | 0% | Dec 2025 |
|
| Millennium Management | 25M | $24M | 100% | Sep 2025 |
|
| Verition Fund Management | 20M | $19M | 100% | Dec 2025 |
|
| Oaktree Capital Management | 20M | $19M | 1231% | Sep 2025 |
|
| Victory Capital Management | 18M | $17M | -3% | Dec 2025 |
|
| Thrivent Financial for Lutherans | 16M | $15M | -1% | Dec 2025 |
|
| CNH Partners | 14M | $13M | -74% | Sep 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $13M | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 13M | $13M | 100% | Sep 2025 |
|
| State Street Corporation | 13M | $12M | 5% | Dec 2025 |
|
| Russell Investments | 6.2M | $5.9M | 77% | Dec 2025 |
|
| Wellesley Investment Advisors | 4.0M | $3.8B | -85% | Dec 2025 |
|
| Palisade Capital Management | 3.7M | $3.5M | 301% | Sep 2025 |
|
| Sonora Investment Management Group | 3.5M | $3.3M | -5% | Sep 2025 |
|
| Colony | 3.4M | $3.3M | 100% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $2.9M | 0% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 2.9M | $2.8M | 0% | Dec 2025 |
|
| Conning | 2.7M | $2.6M | 0% | Dec 2025 |
|
| Wellington Management Company | 2.6M | $2.5M | -15% | Sep 2025 |
|
| Toronto-Dominion Bank | 2.0M | $1.9M | 100% | Sep 2025 |
|
| Wells Fargo & Company | 1.6M | $1.5M | -2% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.2M | $1.2M | 0% | Dec 2025 |
|
| OZ Management | 1.1M | $1.0M | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 983k | $942k | -94% | Dec 2025 |
|
| Leucadia National Corporation | 939k | $901k | 135% | Dec 2025 |
|
| Royal Bank of Canada | 549k | $521k | -83% | Sep 2025 |
|
| Bank of New York Mellon | 546k | $524k | 9% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 534k | $508k | -64% | Sep 2025 |
|
| Kornitzer Capital Management | 500k | $479k | 0% | Dec 2025 |
|
| Sei Investments | 371k | $355k | 0% | Dec 2025 |
|
| Oppenheimer Asset Management | 182k | $174k | 0% | Dec 2025 |
|
| UBS Group | 147k | $141k | 7250% | Dec 2025 |
|
| Raymond James Financial | 96k | $92k | 104% | Dec 2025 |
|
| Stephens | 54k | $52k | 0% | Dec 2025 |
|
| Mml Investors Services | 49k | $47k | 100% | Dec 2025 |
|
| Capital Investment Advisory Services | 43k | $41k | 0% | Dec 2025 |
|
| Mariner Wealth Advisors | 42k | $40k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 42k | $40k | 0% | Dec 2025 |
|
| Ameriprise Financial | 39k | $37k | 22% | Dec 2025 |
|
| Balboa Wealth Partners | 32k | $31k | -3% | Dec 2025 |
|
| Commonwealth Equity Services | 20k | $19k | 100% | Dec 2025 |
|
| Wiley Bros.-aintree Capital | 18k | $17k | -49% | Dec 2025 |
|
| LPL Financial | 17k | $16k | -32% | Dec 2025 |
|
| HB Wealth Management | 11k | $11k | 0% | Dec 2025 |
|
| Davenport & Co | 10k | $960k | 0% | Dec 2025 |
|
| Cetera Investment Advisers | 10k | $9.6k | 0% | Dec 2025 |
|
| Nomura Holdings | 7.5k | $443k | 100% | Dec 2025 |
|
| CoreCap Advisors | 6.0k | $5.7k | 100% | Dec 2025 |
|
| Us Bancorp | 5.0k | $4.8k | 0% | Dec 2025 |
|
| Oddo Bhf Asset Management Sas | 225.00 | $217k | 0% | Dec 2025 |
|
Who sold out of Biomarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ing Investment Management | Sep 2025 | 70M | $66M |
| Franklin Resources | Sep 2025 | 5.7M | $5.4M |
| Macquarie Group | Sep 2025 | 1.9M | $1.8M |
| Prospector Partners | Sep 2025 | 1.0M | $948k |
| Foresight Capital Management Advisors | Sep 2025 | 29k | $28k |
| Rsm Us Wealth Management | Sep 2025 | 28k | $27k |
| Fifth Third Bancorp | Sep 2025 | 11k | $1.0M |
| Brian McDonald | Sep 2025 | 9.0k | $8.5k |